-Reuters
GSK Boosts Its Asthma Product Portfolio With Over $1B Deal For Aiolos Bio
GSK plc (NYSE: GSK) has agreed to acquire Aiolos Bio Inc
Related Posts
Truist Securities Maintains Buy on Broadcom, Raises Price Target to $700
Truist Securities analyst William Stein maintains Broadcom (NASDAQ:AVGO) with a Buy and raises the price target from $659 to $700.
Energy Transfer Announces Increase In Quarterly Cash Distribution From $0.3150 To $0.3175
Energy Transfer LP (NYSE:ET) today announced an increase in its quarterly cash distribution to $0.3175 per Energy Transfer common unit ($1.27 on an annualized basis) for the first quarter ended March 31, 2024.This cash
Lowe’s Companies Earnings Preview
Lowe’s Companies (NYSE:LOW) is set to give its latest quarterly earnings report on Tuesday, 2023-08-22. Here’s what investors…